Renaissance Technologies »

Lyell Immunopharma shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0M 64k 16.24
2025-06-30 $594k 67k 8.84

More positions owned by Renaissance Technologies

Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Roblox Corp Cl A (RBLX)
United Therapeutics Corporation (UTHR)
Verisign (VRSN)
Applovin Corp Com Cl A (APP)
Microsoft Corporation (MSFT)
Kinross Gold Corp (KGC)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
Alphabet Cap Stk Cl A (GOOGL)
Gilead Sciences (GILD)
Doordash Cl A (DASH)
Hims & Hers Health Com Cl A (HIMS)
Reddit Cl A (RDDT)

View all positions for Renaissance Technologies

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Foresite Capital Management IV
Vanguard Group
Orland Properties
Almitas Capital
Foresite Capital Management V
venBio Partners
Citadel Advisors
Alphabet
BlackRock
Sc China Holding
Geode Capital Management
Millennium Management
Rbf Capital

View all funds holding Lyell Immunopharma